| Product Name |
Irinotecan Inhouse Impurity 1 / Irinotecan Acid Sodium Salt
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Enzyme Inhibitors, Fine Chemicals, Chiral Standards |
| CAS No |
1329502-92-2 |
| Catalog Number |
GS.22.IRL.31 |
| Chemical Name/Synonyms |
(S)-7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin acid sodium salt ; (?S)-2-[([1,4'-Bipiperidin]-1'-ylcarbonyl)oxy]-?,12-diethyl-9,11-dihydro-?-hydroxy-8-(hydroxymethyl)-9-oxo-indolizino[1,2-b]quinoline-7-acetic acid sodium salt ; (S)-2-(2-(([1,4'-bipiperidine]-1'-carbonyl)oxy)-12-ethyl-8-(hydroxymethyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-7-yl)-2-hydroxybutanoic acid Sodium Salt ; 142706-06-7 (Free Acid) |
| Molecular Weight |
C33H39N4O7 : Na |
| Molecular Formula |
603.7 : 23.0 |
| Purity |
NLT 95 % |
| Applications |
Carboxylate form of Irinotecan, a DNA topoisomerase inhibitor. |
| Inventory Status |
customized
|
